Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Molecular Pharmaceutics|July 4, 2019
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo BehaviorYana Dekempeneer, Tom Bäck, Emma Aneheim, et al.
EJNMMI Radiopharmacy and Chemistry|July 24, 2024
Generic semi-automated radiofluorination strategy for single domain antibodies: [<sup>18</sup>F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancerHerlinde Dierick, Laurent Navarro, Hannelore Ceuppens, et al.
Cardiovascular Toxicology|June 14, 2011
Integrated backscatter for the in vivo quantification of supraphysiological vitamin D(3)-induced cardiovascular calcifications in ratsBram Roosens, Steven Droogmans, Jeroen Hostens, et al.
Biomolecules|October 2, 2020
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical TranslationJessica Bridoux, Katrijn Broos, Quentin Lecocq, et al.
Frontiers in Immunology|March 26, 2021
Immunogenicity Risk Profile of NanobodiesChloé Ackaert, Natalia Smiejkowska, Catarina Xavier, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 7, 2009
Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological studySteven Droogmans, Bram Roosens, Bernard Cosyns, et al.
European Journal of Medicinal Chemistry|January 13, 2018
Development of potent and proteolytically stable human neuromedin U receptor agonistsAn De Prins, Charlotte Martin, Yannick Van Wanseele, et al.
Ultrasound in Medicine & Biology|December 30, 2008
Echocardiographic and histological assessment of age-related valvular changes in normal ratsSteven Droogmans, Bram Roosens, Bernard Cosyns, et al.
European Heart Journal. Cardiovascular Imaging|January 24, 2016
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaquesGezim Bala, Anneleen Blykers, Catarina Xavier, et al.
Molecular Pharmaceutics|August 14, 2020
Therapeutic Efficacy of <sup>213</sup>Bi-labeled sdAbs in a Preclinical Model of Ovarian CancerYana Dekempeneer, Vicky Caveliers, Maarten Ooms, et al.
Pageof 9